The Journal of Clinical and Translational Science (JCTS) is the official journal of the Association and is published through Cambridge University Press. JCTS accepts high-quality academic content in all areas of clinical and translational science research. Content includes:

• Full research papers
• Reviews
• Brief/expedited reports
• Letters
• Comments
• Special communications

JCTS is a natural forum to highlight advances in the translational science area. All content published is Gold Open Access and available for current members to view. Read the latest issue here and sign up with Cambridge Core to receive alerts when new issues are available.

Members can also share their critical contributions with the translational community by submitting manuscripts for review. JCTS is committed to responding to submitting authors in an expeditious fashion. For more information, including full journal scope, editorial policies and Gold Open Access fees, read the instructions for authors.

Benefits of publishing in JCTS:

• Articles funded by the NIH will be deposited into PubMed Central
• Articles appear with their final citation details as soon as they are published online
• Gold Open Access (Fully compliant with Open Access mandates)
• Global dissemination of your paper
• Metrics, Altmetrics and Kudos to monitor submission
• Prestigious editorial board listing

   

Submit Your Research

If you have questions regarding current and/or previous submissions to the retired journal, CTS, please contact JCTS Editor-in-Chief Dr. Lars Berglund or the JCTS Managing Editor Tracy Candelaria.

Abstract Supplementals

• 2023 Abstract Supplemental
• 2022 Abstract Supplemental
• 2021 Abstract Supplemental
• 2020 Abstract Supplemental
• 2019 Abstract Supplemental
• 2018 Abstract Supplemental
• 2017 Abstract Supplemental